Phase I trial of multiple oral doses of CK 2017357 in healthy male volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2010
At a glance
- Drugs Tirasemtiv (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Cytokinetics
- 13 Dec 2010 Results presented earlier in the year ,according to a Cytokinetics media release
- 22 Jul 2010 Results reported in a Cytokinetics media release.
- 27 Jan 2010 Results reported in a Cytokinetics media release.